Success Metrics

Clinical Success Rate
90.9%

Based on 318 completed trials

Completion Rate
91%(318/350)
Active Trials
158(23%)
Results Posted
3%(10 trials)
Terminated
32(5%)

Phase Distribution

Ph phase_2
13
2%
Ph phase_3
9
1%
Ph phase_4
14
2%
Ph not_applicable
328
48%
Ph phase_1
8
1%
Ph early_phase_1
3
0%

Phase Distribution

11

Early Stage

13

Mid Stage

23

Late Stage

Phase Distribution375 total trials
Early Phase 1First-in-human
3(0.8%)
Phase 1Safety & dosage
8(2.1%)
Phase 2Efficacy & side effects
13(3.5%)
Phase 3Large-scale testing
9(2.4%)
Phase 4Post-market surveillance
14(3.7%)
N/ANon-phased studies
328(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

88.6%

318 of 359 finished

Non-Completion Rate

11.4%

41 ended early

Currently Active

158

trials recruiting

Total Trials

679

all time

Status Distribution
Active(188)
Completed(318)
Terminated(41)
Other(132)

Detailed Status

Completed318
Recruiting132
unknown131
Terminated32
Not yet recruiting27
Active, not recruiting26

Development Timeline

Analytics

Development Status

Total Trials
679
Active
158
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Early Phase 13 (0.8%)
Phase 18 (2.1%)
Phase 213 (3.5%)
Phase 39 (2.4%)
Phase 414 (3.7%)
N/A328 (87.5%)

Trials by Status

enrolling_by_invitation30%
recruiting13219%
withdrawn91%
unknown13119%
completed31847%
suspended10%
active_not_recruiting264%
terminated325%
not_yet_recruiting274%

Recent Activity

Clinical Trials (679)

Showing 20 of 679 trialsScroll for more
NCT04938479

D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure

Completed
NCT04774198

Perioperative Immune Function and Clinical Complications in Pancreaduodenectomy

Completed
NCT02917486

EC-MOTION : ExtraCorporeal Membrane Oxygenation and Therapeutic Drug Monitoring of Drugs of infectION

Completed
NCT05384392Not Applicable

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

Recruiting
NCT06002945

Exploring Outcomes and Characteristics of Myasthenia Gravis 2

Completed
NCT05648136Not Applicable

Immune Profile Analysis and Biomarker Identification in Women With Repeated Implantation Failure or Unexplained Recurrent Spontaneous Miscarriage

Recruiting
NCT01196832Not Applicable

Role of Fibrocytes in Chronic Obstructive Pulmonary Disease

Completed
NCT04789551

T Cell Profiling in Patients With Multiple Sclerosis

Withdrawn
NCT05704530Not Applicable

Liquid Biopsies in Esophageal Cancer

Recruiting
NCT05714592Not Applicable

Evaluation of Optical Genome Mapping in Phi Negative Myeloproliferative Neoplasia in the Detection of Acquired Cytogenetic Abnormalities

Recruiting
NCT05710679Not Applicable

Prediction of Residual Disease by Circulating DNA Detection After Potentiated Radiotherapy for Locally Advanced Head and Neck Cancer

Recruiting
NCT07226466

Evaluating Biomarkers of Cognitive Dysfunction in Patients With Cancer

Not Yet Recruiting
NCT06430021

Study of the Value of hPG80 (Circulating Progastrin) for the Diagnosis of Neuroendocrine Tumours in Patients With an MEN1 Mutation

Recruiting
NCT03841318Not Applicable

Involvement of Immune Cells Derived From the Intestine in Sjogren's Syndrome

Completed
NCT04119908Not Applicable

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Recruiting
NCT04253080Not Applicable

Expression of IL4 Induced Gene 1 in Patients With Cutaneous Melanoma: Value in Prognosis and/or in Predictive Response to Immune Checkpoint Inhibitors

Completed
NCT05288842

Tanycytes in Alzheimer's Disease and Frontotemporal Dementia

Recruiting
NCT07260942Not Applicable

Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus

Recruiting
NCT07592806Not Applicable

CRISTEL Study: Monitoring of Pregnancies in Women After Solid Organ Transplantation

Not Yet Recruiting
NCT03575156Not Applicable

Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis

Completed

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
679